Recent Updates
Recently added Catalysts
BLTE Positive Sentiment Score: 75/100

Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Thursday, August 8, 2024 1 min read
Key Takeaway: Belite Bio, Inc. (NASDAQ: BLTE) has announced that its Chief Scientific Officer, Dr. Nathan Mata, will present a corporate update at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference. The event will take place on August 15, 2024, and will be broadcast at 7:00 am ET. A replay of the presentation will be accessible for 90 days on the company's investor relations website. This update highlights Belite's commitment to advancing therapies for degenerative retinal diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Nathan Mata will provide an update on company progress.
  • The presentation is part of a recognized industry conference.
  • Belite Bio is focusing on addressing significant unmet needs in retinal diseases.

Full Press Release Details

SAN DIEGO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that Dr. Nathan Mata, Chief Scientific Officer of Belite Bio, will present a corporate update at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference.
A webcast of the presentation will be available on Thursday, August 15, 2024, at 7:00 am ET under the "Events" tab on the investor relations section of the Belite Bio website at: https://investors.belitebio.com/presentations-events/events. The replay will be archived for 90 days following the presentation date.
Media Relations Contact:
Investor Relations Contact:
belite@argotpartners.com

Frequently Asked Questions

What company is presenting at the H.C. Wainwright conference?

Belite Bio, Inc. is presenting at the conference.

When is the Belite Bio corporate update presentation scheduled?

The presentation is set for August 15, 2024, at 7:00 am ET.

Who is presenting for Belite Bio at the conference?

Dr. Nathan Mata, Chief Scientific Officer, will present.

Where can I watch the Belite Bio presentation?

The presentation can be viewed on Belite Bio's investor relations website.

How long will the presentation replay be available?

The replay will be available for 90 days after the presentation.

Tags: BLTE Viatris Investor Conferences Healthcare Belite Bio ophthalmology retinal diseases Dr. Nathan Mata
Last updated: Aug 8, 2024